IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Yu Fan

Q4 2023 Holdings

Filed 2024-02-14 | 4 holdings | $20.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cargo Therapeutics(CRGX)COM14179K101$19.0M822,17195.4%
Castle Biosciences(CSTL)COM14843C105$485.6K22,5032.4%
Sagimet Biosciences(SGMT)COM SER A786700104$310.0K57,1901.6%
Pyxis Oncology(PYXS)COMMON STOCK747324101$124.7K69,3030.6%